Literature DB >> 11159110

Reproducibility of hippocampal single-Voxel proton MR spectroscopy and chemical shift imaging.

Y Y Hsu1, M C Chen, K E Lim, C Chang.   

Abstract

OBJECTIVE: We investigated between- and within-acquisition reproducibility of hippocampal metabolite ratios obtained using automated proton MR spectroscopy. SUBJECTS AND METHODS: We examined 30 healthy adults with a 1.5-T scanner four times on 3 days using single-voxel spectroscopy over the left hippocampus, chemical shift imaging over the left hippocampus, and chemical shift imaging over the bilateral hippocampi. Metabolite ratios were derived from the integral values of three major peaks: N:-acetylaspartate (NAA), choline-containing compounds (Cho), and creatine plus phosphocreatine (Cr). The random-effects model of one-way analysis of variance was used to evaluate the reproducibility in terms of coefficient of variation; the mixed-effects model was used to compare the results of different hippocampal regions and spectroscopic techniques.
RESULTS: Most coefficients of variation for the NAA/(Cho+Cr) ratio were less than 20%. All the coefficients of variation for the posterior hippocampus (15-25%) were less than those for the anterior hippocampus (20-44%). The posterior hippocampal NAA/(Cho+Cr) ratio of unilateral chemical shift imaging had the lowest coefficient of variation (<16%). Single-voxel spectroscopy and unilateral chemical shift imaging had similar coefficients of variation for the anterior hippocampal NAA/(Cho+Cr) ratios (17-20%). There was a significant difference in metabolite ratios measured in different hippocampal regions (p<0.01) and in those acquired with different spectroscopic techniques (p<0.001).
CONCLUSION: The NAA/(Cho+Cr) ratio is the most reproducible parameter for hippocampal MR spectroscopy on a 1.5-T scanner. Regional variation and technical differences in metabolite ratios must be considered when interpreting proton spectra of the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159110     DOI: 10.2214/ajr.176.2.1760529

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Quantitative MR analyses of the hippocampus: unspecific metabolic changes in aging.

Authors:  András Szentkuti; Sebastian Guderian; Kolja Schiltz; Jörn Kaufmann; Thomas F Münte; Hans-Jochen Heinze; Emrah Düzel
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

Review 2.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

3.  Physiologic variability of single-voxel proton MR spectroscopic measurements at 3T.

Authors:  R Mark Wellard; Regula S Briellmann; Claire Jennings; Graeme D Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

4.  In vivo intervertebral disc characterization using magnetic resonance spectroscopy and T1ρ imaging: association with discography and Oswestry Disability Index and Short Form-36 Health Survey.

Authors:  Jin Zuo; Gabby B Joseph; Xiaojuan Li; Thomas M Link; Serena S Hu; Sigurd H Berven; John Kurhanewitz; Sharmila Majumdar
Journal:  Spine (Phila Pa 1976)       Date:  2012-02-01       Impact factor: 3.468

5.  Single-voxel (1)H spectroscopy in the human hippocampus at 3 T using the LASER sequence: characterization of neurochemical profile and reproducibility.

Authors:  Najib Allaïli; Romain Valabrègue; Edward J Auerbach; Vincent Guillemot; Lydia Yahia-Cherif; Eric Bardinet; Maritza Jabourian; Philippe Fossati; Stéphane Lehéricy; Małgorzata Marjańska
Journal:  NMR Biomed       Date:  2015-08-18       Impact factor: 4.044

6.  Variance components associated with long-echo-time MR spectroscopic imaging in human brain at 1.5T and 3T.

Authors:  Michael J Thrippleton; Jehill P Parikh; Scott I K Semple; Bridget A Harris; Peter J D Andrews; Joanna M Wardlaw; Ian Marshall
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.